Motus GI lowered the price of its initial public offering from $6 to $5 per share Feb. 14, MarketWatch reports.
Here's what you should know:
1. Motus GI developed the Pure-Vu System, which assists with colonoscopy preparation.
2. Motus was attempting to offer 4.3 million shares initially, but reduced the scope of the offer ahead of the pricing. Motus is now selling 3.5 million shares. Motus had a price range between $5 and $7 per share in the IPO.
3. Motus is trading under the symbol MOTS.